Biological Evaluation of Isoniazid Derivatives as an Anticancer Class
Authors: Rodrigues, F.A.R.; Oliveira, A.C.A.; Cavalcanti, B.C.; Pessoa, C.O.; Pinheiro, A.C.; De Souza, M.V.N. Source: Scientia Pharmaceutica, v. 84, p. 21-28, 2014. Publisher: Austrian Pharmaceutical Society Abstract A series of thirty-two isoniazid derivatives have been evaluated for their activity against four human cancer cell lines with potent cytotoxicity (IC50 ranging from 0.61 to 3.36 μg/mL). […]
